Follicular Lymphoma
📧 Sign up to get email alerts when something new happens for Follicular Lymphoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2016-08-01Clinical Trial Update: Study Evaluating the Efficacy and Safety of PCAR-019 in CD19 Positive Relapsed or Refractory Leukemia and Lymphoma [Phase 1, Phase 2]
Clinical trial update for PCAR-019 evaluating efficacy and safety in CD19-positive relapsed or refractory leukemia and lymphoma across Phase…
-
CLINICAL_TRIALS trial_result · 2016-07-22Clinical Trial Update: Safety and Efficacy of Single Agent Obatoclax Mesylate (GX15-070MS) Followed by a Combination With Rituximab for Previously-untreated Follicular Lymphoma (FL) [Phase 2]
Phase 2 clinical trial evaluating safety and efficacy of single-agent obatoclax mesylate followed by rituximab in previously untreated folli…
-
CLINICAL_TRIALS trial_result · 2016-07-12Clinical Trial Update: Trial of Low-Dose Methotrexate and I 131 Tositumomab for Previously Untreated, Advanced-Stage, Follicular Lymphoma [Phase 2]
Phase 2 trial evaluating low-dose methotrexate in combination with I-131 labeled tositumomab for previously untreated advanced-stage follicu…
-
CLINICAL_TRIALS trial_result · 2016-07-01Clinical Trial Update: Cyclophosphamide and Filgrastim in Treating Patients With Stage IV, Relapsed, or Refractory Low-Grade Follicular Non-Hodgkin's Lymphoma [Phase 2]
The document reports the completion of a Phase 2 trial evaluating the combination of cyclophosphamide and filgrastim in patients with stage …
-
FDA approval · 2016-06-23FDA Approved: BENDEKA — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved a supplemental application for Bendeka (bendamustine hydrochloride) submitted by Teva Pharmaceuticals USA, Inc., indicating reg…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2016-06-17Clinical Trial Update: Y90 Ibritumomab Tiuxetan Post R-CHOP Chemotherapy for Advanced Stage Follicular Lymphoma [Phase 2]
Phase 2 trial evaluating Y-90 ibritumomab tiuxetan after R-CHOP chemotherapy in advanced-stage follicular lymphoma has completed.
-
CLINICAL_TRIALS research · 2016-06-06Clinical Trial Update: Identification of Hematological Malignancies and Therapy Predication Using microRNAs as a Diagnostic Tool
Clinical trial update describes research on using microRNAs as a diagnostic tool to identify hematological malignancies and predict therapeu…
-
CLINICAL_TRIALS trial_result · 2016-06-03Clinical Trial Update: Monoclonal Antibody CT-011 in Combination With Rituximab in Patients With Relapsed Follicular Lymphoma [Phase 2]
Phase 2 trial evaluating CT-011 in combination with rituximab for relapsed follicular lymphoma has completed, with results posted in 2016.
-
CLINICAL_TRIALS trial_result · 2016-04-25Clinical Trial Update: A Study of Obinutuzumab in Chinese Participants With CD20+ Malignant Disease [Phase 1]
Phase 1 trial results for obinutuzumab in Chinese participants with CD20+ malignant disease. Diseases studied include chronic lymphocytic le…
-
CLINICAL_TRIALS trial_result · 2016-04-04Clinical Trial Update: Rituximab and CVP Plus Interferon for Follicular Non Hodgkins Lymphoma (NHL) [Phase 2]
This document provides an update on a Phase 2 trial evaluating rituximab with CVP chemotherapy plus interferon for follicular non-Hodgkin ly…
-
CLINICAL_TRIALS trial_result · 2016-03-30Clinical Trial Update: A Study of Ocrelizumab in Participants With Follicular Non-Hodgkin's Lymphoma (NHL) [Phase 1, Phase 2]
A completed Phase 1/2 clinical trial evaluating ocrelizumab in participants with follicular non-Hodgkin's lymphoma.
-
CLINICAL_TRIALS trial_result · 2016-03-15Clinical Trial Update: A Phase I/II Trial of VR-CHOP in Lymphoma Patients [Phase 1, Phase 2]
This clinical trial update reports results from a Phase I/II study of VR-CHOP in patients with B-cell non-Hodgkin lymphoma, including follic…
-
EMA safety_alert · 2016-03-11EMA reviews cancer medicine Zydelig
The EMA reviews the cancer medicine Zydelig (idelalisib) for potential safety concerns and evaluates available data.
-
CLINICAL_TRIALS trial_result · 2016-03-01Clinical Trial Update: Brief Chemoimmunotherapy With R+B+M Followed by R in Elderly Patients Advanced Stage Untreated Follicular Lymphoma [Phase 2]
This Phase 2 trial evaluated a chemoimmunotherapy regimen of rituximab, bendamustine, and mitoxantrone followed by rituximab in elderly pati…
-
CLINICAL_TRIALS trial_result · 2016-02-25Clinical Trial Update: Prospective Observational Study on the Management of Patients With Relapsed or Refractory Follicular Lymphoma (OLYMPE)
Hoffmann-La Roche conducted a prospective observational study evaluating the management of patients with relapsed or refractory follicular l…
-
CLINICAL_TRIALS trial_result · 2016-02-15Clinical Trial Update: A Pilot Study of Oral Vorinostat Plus Oral Eltrombopag Support in Patients With Lymphoma (VEIL) [Phase 2]
Phase 2 pilot trial of oral vorinostat plus eltrombopag in lymphoma was terminated.
-
CLINICAL_TRIALS research · 2016-01-28Clinical Trial Update: Treatment of Relapsed and/or Chemotherapy Refractory B-cell Malignancy by CART19 [NA]
Clinical trial update describing CART19 therapy for relapsed and/or chemotherapy-refractory B-cell malignancies with an unknown status of th…
-
CLINICAL_TRIALS trial_result · 2016-01-11Clinical Trial Update: Rituximab or Zevalin - Efficacy Trial of Therapeutic Alternatives (RoZetta) [Phase 3]
Phase 3 trial RoZetta comparing Rituximab versus Zevalin in follicular lymphoma was terminated with results posted in 2016.
-
CLINICAL_TRIALS trial_result · 2016-01-08Clinical Trial Update: MORAb-004 in Treating Young Patients With Recurrent or Refractory Solid Tumors or Lymphoma [Phase 1]
Phase 1 trial update for MORAb-004 in young patients with recurrent or refractory solid tumors or lymphoma; the study has been completed.
-
CLINICAL_TRIALS trial_result · 2015-12-22Clinical Trial Update: GM-CSF and Rituximab After Autologous Stem Cell Transplant in Treating Patients With Relapsed or Refractory Follicular Non-Hodgkin Lymphoma [Phase 2]
A Phase 2 trial evaluated GM-CSF and rituximab after autologous stem cell transplant in patients with relapsed or refractory follicular non-…
-
CLINICAL_TRIALS trial_result · 2015-12-17Clinical Trial Update: Radiolabeled Monoclonal Antibody Plus Rituximab With and Without Filgrastim and Interleukin-11 in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma [Phase 1, Phase 2]
A Phase 1/2 trial evaluating a radiolabeled monoclonal antibody with rituximab, with/without filgrastim and interleukin-11, in relapsed or r…
-
CLINICAL_TRIALS trial_result · 2015-12-14Clinical Trial Update: Efficacy of Consolidative Involved-site Radiotherapy for Patients With Limited-stage Follicular Lymphoma [Phase 3]
A Phase 3 clinical trial evaluating whether consolidative involved-site radiotherapy improves outcomes in patients with limited-stage follic…
-
CLINICAL_TRIALS trial_result · 2015-12-14Clinical Trial Update: Efficacy of Palliative Low-Dose Involved-Field Radiation Therapy for Recurrent Advanced Follicular Lymphoma [Phase 3]
A Phase 3 clinical trial assesses the efficacy of low-dose palliative involved-field radiation therapy for recurrent advanced follicular lym…
-
CLINICAL_TRIALS trial_result · 2015-12-10Clinical Trial Update: A Study of Long-Term Rituximab (MabThera) Maintenance Therapy in Participants With Advanced Follicular Lymphoma [Phase 3]
A Phase 3 study evaluating long-term rituximab maintenance therapy in participants with advanced follicular lymphoma, with results posted in…
-
CLINICAL_TRIALS trial_result · 2015-12-04Clinical Trial Update: Obatoclax and Bortezomib in Treating Patients With Aggressive Relapsed or Recurrent Non-Hodgkin Lymphoma [Phase 1]
Phase 1 trial of obatoclax with bortezomib in adults with aggressive relapsed or recurrent non-Hodgkin lymphoma has been terminated.